 |
ARCHIVE # 4: 554 ARTICLES (NOV -SEPT 2006) |
|
|||||
My Educational Video on MS and MS Trials| Visitors Since 03/2006 |
||||||||||||||||||||||||||||||||||||||||
| Click here to read messages from our MySpace Friends HERE'S A FEW OF OUR 1,404 MySpace FRIENDS |
||||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||
 Click to view 1280 MS Walk photos! | ||||||||||||||||||||||||||||||||||||||||
| "Join a trial at Barrow & receive all medication & study based procedures at no charge!" | ||||||||||||||||||||||||||||||||||||||||
Stan Swartz, CEO, The MD Health Channel "WE PRODUCED THE FOLLOWING 9 VIDEOS FOR YOU!" Simply click the "video" buttons below: . |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
| Previious Posts | ||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
| MS NEWS ARCHIVES: by week | ||||||||||||||||||||||||||||||||||||||||
| September 2006 | ||||||||||||||||||||||||||||||||||||||||
| October 2006 | ||||||||||||||||||||||||||||||||||||||||
| November 2006 | ||||||||||||||||||||||||||||||||||||||||
| July 2013 | ||||||||||||||||||||||||||||||||||||||||
| April 2014 | ||||||||||||||||||||||||||||||||||||||||
Friday, September 29, 2006
ABOUT ECTRIMS:
ECTRIMS....22nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis
September 27–30, 2006 / Madrid, Spain
CLICK HERE TO GO TO ECTRIMS HOME PAGE
(This international meeting fosters collaboration and cross-pollination between basic and clinical MS researchers to propel the search for better therapies and a cure)
ECTRIMS WELCOME LETTER TO ALL DOCTORS:
"Dear colleagues and friends,
We warmly welcome you in Madrid for the 22nd meeting of the European Committee for Treatment and Research in Multiple Sclerosis. Over the last years, MS therapy has become increasingly complex. New medications are in various stages of development and the need for assessing their efficacy is bigger than ever.
However, the availability of approved drugs has created significant obstacles to the conduct of classical placebo-controlled clinical trials. Furthermore, the partial efficacy of the licensed medications poses the need for combining existing and new drugs. These matters will be reviewed in two of the main topics.
Separate sessions will be devoted to a selection of important topics such as paediatric MS, advances in immunology, recent insights into basic mechanisms of CNS damage, the complex role of the cannabinoid system in immuneregulation and tissue protection, the usefulness of CSF analysis in the era of the new diagnostic criteria and new aspects of the natural history of MS.
Whether or not the incidence of MS is increasing, the role of conventional MRI as a means to assess the patient’s evolution, advances in functional MRI and the concept and therapeutic approach to breakthrough MS will be discussed under the heading of “practical issues in MS”.
Madrid is a vital and exciting city that can certainly make your stay very pleasant. Please spare some of your time to enjoy the many resources that this city offers to the visitor.
Welcome to ECTRIMS 2007 – Welcome to Madrid!
A. Garcia-Merino L. Kappos H.-P. Hartung
September 27–30, 2006 / Madrid, Spain
CLICK HERE TO GO TO ECTRIMS HOME PAGE
(This international meeting fosters collaboration and cross-pollination between basic and clinical MS researchers to propel the search for better therapies and a cure)
ECTRIMS WELCOME LETTER TO ALL DOCTORS:
"Dear colleagues and friends,
We warmly welcome you in Madrid for the 22nd meeting of the European Committee for Treatment and Research in Multiple Sclerosis. Over the last years, MS therapy has become increasingly complex. New medications are in various stages of development and the need for assessing their efficacy is bigger than ever.
However, the availability of approved drugs has created significant obstacles to the conduct of classical placebo-controlled clinical trials. Furthermore, the partial efficacy of the licensed medications poses the need for combining existing and new drugs. These matters will be reviewed in two of the main topics.
Separate sessions will be devoted to a selection of important topics such as paediatric MS, advances in immunology, recent insights into basic mechanisms of CNS damage, the complex role of the cannabinoid system in immuneregulation and tissue protection, the usefulness of CSF analysis in the era of the new diagnostic criteria and new aspects of the natural history of MS.
Whether or not the incidence of MS is increasing, the role of conventional MRI as a means to assess the patient’s evolution, advances in functional MRI and the concept and therapeutic approach to breakthrough MS will be discussed under the heading of “practical issues in MS”.
Madrid is a vital and exciting city that can certainly make your stay very pleasant. Please spare some of your time to enjoy the many resources that this city offers to the visitor.
Welcome to ECTRIMS 2007 – Welcome to Madrid!
A. Garcia-Merino L. Kappos H.-P. Hartung